- ZTS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $126.2 million.
- ZTS has traded 1.2 million shares today.
- ZTS traded in a range 291.9% of the normal price range with a price range of $1.94.
- ZTS traded above its daily resistance level (quality: 530 days, meaning that the stock is crossing a resistance level set by the last 530 calendar days. The resistance price is defined by the Price - $0.01 at the time of the signal).
Stocks matching the 'Barbarian at the Gate' criteria are worthwhile stocks to watch for a variety of factors including historical back testing and volatility. Trade-Ideas targets these opportunities because the stock is exhibiting an unusual behavior while displaying positive price action. In this case, the stock crossed an important inflection point; namely, 'resistance' while at the same time the range of the stock's movement in price is more than twice its normal size. This large range foreshadows a possible continuation as the stock moves higher. EXCLUSIVE OFFER: Get the inside scoop on opportunities in ZTS with the Ticky from Trade-Ideas. See the FREE profile for ZTS NOW at Trade-Ideas More details on ZTS: Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. The stock currently has a dividend yield of 0.9%. ZTS has a PE ratio of 31. The average volume for Zoetis has been 2.8 million shares per day over the past 30 days. Zoetis has a market cap of $18.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.81 and a short float of 1% with 2.82 days to cover. Shares are up 15.2% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.